Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of a Low Advanced Glycation End Products Diet Blood Biomarkers of Patients With Type 2 Diabetes Mellitus: Randomized Controlled Trial.

NCT07303842 is registered in ClinicalTrials.gov with InCor Heart Institute as lead sponsor.

NCT NCT07303842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07303842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of a Low Advanced Glycation End Products Diet Blood Biomarkers of Patients With Type 2 Diabetes Mellitus: Randomized Controlled Trial.
Lead sponsor
InCor Heart Institute
Phase
Not applicable
Overall status
Completed
Start date
March 8, 2022
Completion date
December 1, 2024
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad), type 2 diabetes